Haematopoietic progenitor cells (HPCs) are a group of cells produced by haematopoietic stem cells. Haematopoietic progenitor cells will differentiate into kinds of blood cells. The HPCs are found in the bone marrow and will develop into other blood cells. Compared to haematopoietic stem cells, HPCs are slightly more specific in what type of blood cells they will eventually become. That means HPCs cannot differentiate into all types of blood cells.
HPCs are widely used in clinic applications. Haematopoietic progenitor cell transplantation is important and effective to correct defects in bone marrow. It is the most efficient treatment for leukaemia. In addition, HPCs used to recover functions of bone marrow avoiding the damage causing by chemotherapy and/or radiotherapy. As a primary manufacturer, Creative biomart provides a variety of recombinant proteins related to HPCs for research applications.